Prevalence and Risk Factors for Common Diseases

October 4, 2019 updated by: Anna Nordström

Prevalence and Risk Factors for Common Diseases in Sweden: A Nationwide Cohort Study

By using national databases in Sweden the aim of the present project is to:

  1. Investigate if the incidence of our most common diseases, such as fracture and cardiovascular disease, has changed from 1970-2017
  2. To investigate whether the risk of death for our most common diseases have changed from 1970-2017.
  3. To investigate the risk of a new episode after suffering from our most common diseases from 1970-2017
  4. To investigate the risk factors for our most common diseases, and whether these have changed from 1970.
  5. To investigate how severe disease or death affects the health of a close relative.

Study Overview

Detailed Description

Please see above on the summary.

Study Type

Observational

Enrollment (Anticipated)

1000000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Se above

Description

Inclusion Criteria:

  • All people living in Sweden that is diagnosed with our most common diseases between 1970-2017.

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of disease
Time Frame: 1970-2017
To investigate the incidence of the most common diseases, and whether the incidence has changed.
1970-2017
Age at diagnosis of disease
Time Frame: 1970-2017
To investigate age at diagnosis of our most common diseases, and whether this has changed.
1970-2017
Risk of death or disease in relative
Time Frame: 1970-2017
Risk of death or disease in close relative to those diagnosed with severe disease or died.
1970-2017
Risk factors for disease or death
Time Frame: 1970-2017
Risk factors for our most common diseases or death
1970-2017

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk for readmission
Time Frame: 1970-2017
To investigate the risk of readmission for our most common diseases, and whether this risk has changed,
1970-2017

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Study Director: Peter Nordström, Professor, Umea University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 1, 2019

Primary Completion (Anticipated)

November 1, 2020

Study Completion (Anticipated)

November 1, 2020

Study Registration Dates

First Submitted

September 13, 2019

First Submitted That Met QC Criteria

September 13, 2019

First Posted (Actual)

September 16, 2019

Study Record Updates

Last Update Posted (Actual)

October 8, 2019

Last Update Submitted That Met QC Criteria

October 4, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • VasterbottenCounty

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on To describe the incidence of disease and evaluate risk factors

3
Subscribe